REGULATORY

Vaccine Industry Group Calls for Govt’s Control Functions for Infectious Diseases

April 21, 2021

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

The Japan Association of Vaccine Industries on April 20 urged the government to establish control tower functions to promote public-private-academic cooperation and collaborations between companies and global partners in the infectious disease arena. It also stressed the need for support…

To read the full story

Ruling Party Members Mull Govt’s Stronger Control Functions for Infectious Diseases, with Future COVID-19 Measures in Mind
June 26, 2020

REGULATORY

Japan to Cut Drug Prices by 0.86% in FY2026; Central Govt Savings Seen at 105 Billion Yen
December 25, 2025
Japan Growth Strategy Council to Set Up Drug Discovery Working Group
December 25, 2025
Japan Ministers Agree to Scrap “Spillover” Rule, Plan Wider CEA Price Cuts
December 25, 2025
Takeda Plans January Rollout of Overseas Plasma-Derived Ig amid Suspension
December 25, 2025
Japan Panel OKs Label Warning Update for Labor Inducers to Mention Epidural Births
December 25, 2025

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo Backs Draft FY2026 Pricing Reform Outline, Rejects Key Industry Requests

By Takashi Ebisawa

The Ministry of Health, Labor and Welfare (MHLW) on December 12 presented a draft outline of the FY2026 drug pricing…

COLUMN

AI: Your New HR BFF (Not Your Replacement!)

By Philip Carrigan

Let’s ditch the stuffy jargon and talk about AI in HR like real humans.One of the biggest myths floating around is that AI is coming to steal our jobs. Newsflash: that’s not happening. Sure, AI can handle the boring stuff…

COMMENTARY

Radioligand Therapy Faces Capacity Bottleneck in Japan, System Build-Out Needed to Deliver on Promise

By Koji Shimomura

Novartis’ Pluvicto (lutetium vipivotide tetraxetan (177Lu)) won reimbursement listing in Japan in November as a radioligand therapy (RLT) for PSMA-positive…